170 related articles for article (PubMed ID: 36428708)
1. Brachytherapy in the Treatment of Non-Melanoma Skin Peri-Auricular Cancers-A Retrospective Analysis of a Single Institution Experience.
Bilski M; Cisek P; Baranowska I; Kordzińska-Cisek I; Komaniecka N; Hymos A; Grywalska E; Niedźwiedzka-Rystwej P
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428708
[TBL] [Abstract][Full Text] [Related]
2. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
3. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
4. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
Lin L; Patel RR; Thomadsen BR; Henderson DL
Med Phys; 2008 Jan; 35(1):240-7. PubMed ID: 18293579
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer.
Wazer DE; Berle L; Graham R; Chung M; Rothschild J; Graves T; Cady B; Ulin K; Ruthazer R; DiPetrillo TA
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):889-97. PubMed ID: 12095554
[TBL] [Abstract][Full Text] [Related]
6. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
7. High dose brachytherapy with non sealed
Castellucci P; Savoia F; Farina A; Lima GM; Patrizi A; Baraldi C; Zagni F; Vichi S; Pettinato C; Morganti AG; Strigari L; Fanti S
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1511-1521. PubMed ID: 33140131
[TBL] [Abstract][Full Text] [Related]
8. HDR brachytherapy for superficial non-melanoma skin cancers.
Gauden R; Pracy M; Avery AM; Hodgetts I; Gauden S
J Med Imaging Radiat Oncol; 2013 Apr; 57(2):212-7. PubMed ID: 23551783
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy in treatment of non-melanoma skin cancer of head and neck region: preliminary results of a prospective single institution study.
Kalaghchi B; Esmati E; Ghalehtaki R; Gomar M; Jaberi R; Gholami S; Babaloui S; Nabavi M; Sotoudeh S; Khanjani N; Kazemian A; Amouzegar-Hashemi F; Aghili M; Lashkari M
J Contemp Brachytherapy; 2018 Apr; 10(2):115-122. PubMed ID: 29789760
[TBL] [Abstract][Full Text] [Related]
10. High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.
Niehoff P; Dietrich J; Ostertag H; Schmid A; Kohr P; Kimmig B; Kovács G
Strahlenther Onkol; 2006 Feb; 182(2):102-7. PubMed ID: 16447017
[TBL] [Abstract][Full Text] [Related]
11. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
12. Interstitial high-dose-rate brachytherapy boost: the feasibility and cosmetic outcome of a fractionated outpatient delivery scheme.
Manning MA; Arthur DW; Schmidt-Ullrich RK; Arnfield MR; Amir C; Zwicker RD
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1301-6. PubMed ID: 11121626
[TBL] [Abstract][Full Text] [Related]
13. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study.
Guix B; Henríquez I; Andrés A; Finestres F; Tello JI; Martínez A
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):167-72. PubMed ID: 11316560
[TBL] [Abstract][Full Text] [Related]
14. PDR brachytherapy with flexible implants for interstitial boost after breast-conserving surgery and external beam radiation therapy.
Fritz P; Berns C; Anton HW; Hensley F; Assman J; Flentje M; von Fournier D; Wannenmacher M
Radiother Oncol; 1997 Oct; 45(1):23-32. PubMed ID: 9364628
[TBL] [Abstract][Full Text] [Related]
15. Interstitial HDR Brachytherapy in the Treatment of Non-Melanocytic Skin Cancers around the Eye.
Cisek P; Kieszko D; Bilski M; Dębicki R; Grywalska E; Hrynkiewicz R; Bębnowska D; Kordzińska-Cisek I; Rolińska A; Niedźwiedzka-Rystwej P; Grzybowska-Szatkowska L
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33804710
[TBL] [Abstract][Full Text] [Related]
16. Improving the dosimetric coverage of interstitial high-dose-rate breast implants.
Kestin LL; Jaffray DA; Edmundson GK; Martinez AA; Wong JW; Kini VR; Chen PY; Vicini FA
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):35-43. PubMed ID: 10656370
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant.
Lawenda BD; Taghian AG; Kachnic LA; Hamdi H; Smith BL; Gadd MA; Mauceri T; Powell SN
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):671-80. PubMed ID: 12788172
[TBL] [Abstract][Full Text] [Related]
18. Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.
Martinez AA; Kestin LL; Stromberg JS; Gonzalez JA; Wallace M; Gustafson GS; Edmundson GK; Spencer W; Vicini FA
Int J Radiat Oncol Biol Phys; 2000 May; 47(2):343-52. PubMed ID: 10802358
[TBL] [Abstract][Full Text] [Related]
19. TLD skin dose measurements and acute and late effects after lumpectomy and high-dose-rate brachytherapy only for early breast cancer.
Perera F; Chisela F; Stitt L; Engel J; Venkatesan V
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1283-90. PubMed ID: 16029783
[TBL] [Abstract][Full Text] [Related]
20. Thermal boost combined with interstitial brachytherapy in breast conserving therapy - Assessment of early toxicity.
Chicheł A; Skowronek J; Kanikowski M
Rep Pract Oncol Radiother; 2011; 16(3):87-94. PubMed ID: 24376963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
